Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$64.3M
7 rounds on record
Latest round
$32.8M
Venture round · Feb 2026 · 7 mo ago
Team
201-500
employees, estimated range
Revenue
$1M
2020 · SEC Form D 0001703764-21-000001
Backers
1
OrbiMed
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 26
Raised a round Venture round $32.8M · SEC Form D
Jun 4, 2024
Took on debt financing $1.2M · SEC Form D
Jun 1, 2023
Raised a round Venture round $4.8M · SEC Form D
Jul 28, 2022
Raised a round Venture round $2M · SEC Form D
Nov 15, 2021
Raised a round Venture round $5M · SEC Form D
Apr 6, 2017
Raised a round Convertible Note $9.8M · SEC Form D
Apr 6, 2017
Raised a round Convertible Note $9.8M · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2026 | $32.8M | — | SEC Form D |
| Debt Financing | Jun 2024 | $1.2M | — | SEC Form D |
| Venture round | Jun 2023 | $4.8M | — | SEC Form D |
| Venture round | Jul 2022 | $2M | — | SEC Form D |
| Venture round | Nov 2021 | $5M | — | SEC Form D |
| Convertible Note | Apr 2017 | $9.8M | — | SEC Form D |
| Convertible Note | Apr 2017 | $9.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Thrombolex, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Marvin WoodallExecutive Officer, DirectorSEC Form D
Michael CerminaroExecutive Officer, DirectorSEC Form D
John CerminaroExecutive OfficerSEC Form D
Brian FirthExecutive Officer, DirectorSEC Form D
Tony LitwillerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
People

Marvin Woodall
Executive Officer, Director

Michael Cerminaro
Executive Officer, Director

John Cerminaro
Executive Officer

Brian Firth
Executive Officer, Director

Tony Litwiller
Executive Officer

Paul Stewart
Director

Todd Richmond
Director

Kelly Elliott
Director

David Bonita
Director

Keegan Harper
Director

Sam Liang
Director

Clay DeMarcus
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Doylestown
United States
HQ
200-500 est. staff
Financials
Est. Annual Revenue
$500k
2020
Total raised
$65.5M
Latest round
Venture - Series Unknown
Funding rounds
7
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $32.8M | Details |
| Debt Financing | 2024 | $1.2M | Details |
| Venture - Series Unknown | 2023 | $4.8M | Details |
| Venture - Series Unknown | 2022 | $2M | Details |
| Venture - Series Unknown | 2021 | $5M | Details |
| Convertible Note | 2017 | $9.8M | Details |
| Convertible Note | 2017 | $9.8M | Details |

OrbiMed